STU:WPS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
STU:WPS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. West Pharmaceutical Services's annualized Gross Profit for the quarter that ended in Sep. 2024 was €954 Mil. West Pharmaceutical Services's average Total Assets over the quarter that ended in Sep. 2024 was €3,276 Mil. Therefore, West Pharmaceutical Services's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 was 29.12%.
The historical data trend for West Pharmaceutical Services's Gross-Profit-to-Asset % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
West Pharmaceutical Services Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Gross-Profit-to-Asset % | Get a 7-Day Free Trial | 28.34 | 28.66 | 39.80 | 33.80 | 29.90 |
West Pharmaceutical Services Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Gross-Profit-to-Asset % | Get a 7-Day Free Trial | 31.30 | 29.03 | 24.82 | 26.07 | 29.12 |
For the Medical Instruments & Supplies subindustry, West Pharmaceutical Services's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, West Pharmaceutical Services's Gross-Profit-to-Asset % distribution charts can be found below:
* The bar in red indicates where West Pharmaceutical Services's Gross-Profit-to-Asset % falls into.
West Pharmaceutical Services's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:
Gross-Profit-to-Asset % | = | Gross Profit (A: Dec. 2023 ) | / | ( (Total Assets (A: Dec. 2022 ) | + | Total Assets (A: Dec. 2023 )) | / count ) |
= | 1035.476 | / | ( (3414.259 | + | 3511.651) | / 2 ) | |
= | 1035.476 | / | 3462.955 | ||||
= | 29.90 % |
West Pharmaceutical Services's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 is calculated as:
Gross-Profit-to-Asset % | = | Gross Profit (Q: Sep. 2024 ) | / | ( (Total Assets (Q: Jun. 2024 ) | + | Total Assets (Q: Sep. 2024 )) | / count ) |
= | 953.98 | / | ( (3241.653 | + | 3311.265) | / 2 ) | |
= | 953.98 | / | 3276.459 | ||||
= | 29.12 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Sep. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.
Thank you for viewing the detailed overview of West Pharmaceutical Services's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.